What is the current price / NAV of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The current NAV of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund is ₹42.92, as of 11th July 2025.What are the returns of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund was launched on 13th July 2018. This mutual fund's past returns are as follows:- 1 Year Returns: 18.56%
- 3 Year Returns: 30.01%
- 5 Year Returns: 25.57%
What are the top 5 sectoral holdings of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The top sectors ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund has invested in are as follows:- Pharmaceuticals | 84.38%
- Others | 7.00%
- Labs & Life Sciences Services | 3.70%
- Miscellaneous | 2.56%
- Diversified Chemicals | 1.29%
What are the top 5 holdings of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The top 5 holdings for ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund are as follows:- Sun Pharmaceutical Industries Ltd | 12.23%
- Divi's Laboratories Ltd | 8.95%
- Dr Reddy's Laboratories Ltd | 8.92%
- Cipla Ltd | 7.75%
- Aurobindo Pharma Ltd | 6.06%
What is the asset allocation of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The asset allocation for ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund is as follows:- Equity | 96.45%
- Cash & Equivalents | 3.55%
What is the AUM of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The AUM (i.e. assets under management) of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund is ₹5727.59 Cr as of 11th July 2025.What is the expense ratio of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The expense ratio of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund Plan is 1.05 as of 11th July 2025.What is the alpha ratio of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The alpha ratio for the ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund is 2.55
Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.
What is the volatility or standard deviation of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The volatility or standard deviation for the ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund is 15.16
Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.
What is the sharpe ratio of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The Sharpe ratio for the ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund is 0.94
The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.
What is the Sortino ratio of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The Sortino Ratio for the ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund is 0.09
The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.
What is the Price to Earnings (PE) ratio of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The PE ratio of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund is 41.06, while category PE ratio is 58.82.
Gains are treated as short-term capital gains and taxed at 20%
Gains are treated as long-term capital gains and taxed at 12.5%